Key financial indicators
Overview of key financial indicators in 1-6 2022
| Sales (in HRKm) | 1-6 2022 | 1-6 2021 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 2,443.8 | 2,238.2 | 9.2% |
| Sales revenues of Podravka Group | 2,416.2 | 2,220.5 | 8.8% |
| Sales revenues of Food | 1,913.8 | 1,716.6 | 11.5% |
| Sales revenues of Pharma | 502.4 | 503.9 | -0.3% |
| Podravka Group's profitability (in HRKm) | 1-6 2022 | 1-6 2021 | % change |
| Group's gross profit | 881.1 | 843.2 | 4.5% |
| Group's gross profit margin | 36.5% | 38.0% | -151 bb |
| Group's EBITDA | 365.2 | 356.6 | 2.4% |
| Group's EBITDA margin | 15.1% | 16.1% | -94 bb |
| Group's EBIT | 252.5 | 248.7 | 1.5% |
| Group's EBIT margin | 10.5% | 11.2% | -75 bb |
| Group's net profit after MI | 198.2 | 197.6 | 0.3% |
| Group's net profit margin after MI | 8.2% | 8.9% | -69 bb |
| Podravka Group's balance sheet (in HRKm) | 30.6.2022 | 31.12.2021 | % change |
| Total assets | 5,285.3 | 4,909.0 | 7.7% |
| Shareholders' equity | 3,732.8 | 3,631.0 | 2.8% |
| Minority interests | 68.1 | 63.3 | 7.6% |
| Cash and cash equivalents | 219.5 | 33.3 | 559.1% |
| Financial debt | 388.1 | 493.8 | -21.4% |
| Net debt | 168.6 | 460.5 | -63.4% |
| Podravka Group's cash flow (in HRKm) | 1-6 2022 | 1-6 2021 | % change |
| Net cash flow from operating activities | 503.0 | 359.7 | 39.8% |
| Capital expenditures | (203.8) | (56.5) | 37.8% |
| Depreciation and amortization | 107.8 | 112.7 | -4.3% |
| Free cash flow | 706.8 | 416.3 | 69.8% |
| Podravka Group's ratios and indicators | 30.6.2022 | 31.12.2021 | % change |
| Employee number at the end of period (in units) | 6,545 | 6,557 | -0.2% |
| P&L interest expense (in HRKm) | 5.8 | 6.8 | -20.9% |
| Sales revenues / Number of employees (in HRK000) | 736.9 | 706.3 | 4.3% |
| Net profit after MI / Sales revenues (in HRK000) | 47.3 | 47.2 | 0.3% |
| Return on average assets | 6.1% | 6.3% | -26 bb |
| Return on average capital | 8.3% | 8.8% | -50 bb |
| Return on average invested capital | 7.9% | 7.7% | +20 bb |
| Total shareholders' equity / Total assets | 71.9% | 75.3% | -334 bb |
| EBIT / P&L interest expense | 66.9 | 56.9 | 17.6% |
| Net debt / EBITDA | 0.3 | 0.8 | -63.7% |
| Sales (in HRKm) | 1-3 2022 | 1-3 2021 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 1,177.3 | 1,089.8 | 8.0% |
| Sales revenues of Podravka Group | 1,172.6 | 1,079.7 | 8.6% |
| Sales revenues of Food | 936.9 | 845.3 | 10.8% |
| Sales revenues of Pharma | 235.7 | 234.3 | 0.6% |
| Podravka Group's profitability (in HRKm) | 1-3 2022 | 1-3 2021 | % change |
| Group's gross profit | 435.6 | 411.8 | 5.8% |
| Group's gross profit margin | 37.1% | 38.1% | -100 bb |
| Group's EBITDA | 170.3 | 184.5 | -7.7% |
| Group's EBITDA margin | 14.5% | 17.1% | -257 bb |
| Group's EBIT | 115.2 | 131.1 | -12.2% |
| Group's EBIT margin | 9.8% | 12.1% | -232 bb |
| Group's net profit after MI | 88.8 | 105.2 | -15.6% |
| Group's net profit margin after MI | 7.6% | 9.7% | -217 bb |
| Podravka Group's balance sheet (in HRKm) | 31.3.2022 | 31.12.2021 | % change |
| Total assets | 5,215.0 | 4,909.0 | 6.2% |
| Shareholders' equity | 3,730.0 | 3,631.0 | 2.7% |
| Minority interests | 66.5 | 63.3 | 5.1% |
| Cash and cash equivalents | 214.8 | 33.3 | 545.0% |
| Financial debt | 435.8 | 493.8 | -11.8% |
| Net debt | 221.0 | 460.5 | -52.0% |
| Podravka Group's cash flow (in HRKm) | 1-3 2022 | 1-3 2021 | % change |
| Net cash flow from operating activities | 317.6 | 190.6 | 66.6% |
| Capital expenditures | (63.4) | (18.8) | 37.8% |
| Depreciation and amortization | 55.2 | 53.4 | 3.3% |
| Free cash flow | 381.0 | 209.4 | 81.9% |
| Podravka Group's ratios and indicators | 31.3.2022 | 31.12.2021 | % change |
| Employee number at the end of period (in units) | 6,551 | 6,557 | -0.1% |
| P&L interest expense (in HRKm) | 6.3 | 6.8 | -20.9% |
| Sales revenues / Number of employees (in HRK000) | 721.2 | 706.3 | 2.1% |
| Net profit after MI / Sales revenues (in HRK000) | 44.7 | 47.2 | -5.2% |
| Return on average assets | 5.9% | 6.3% | -49 bb |
| Return on average capital | 7.9% | 8.8% | -86 bb |
| Return on average invested capital | 7.5% | 7.7% | -18 bb |
| Total shareholders' equity / Total assets | 72.8% | 75.3% | -246 bb |
| EBIT / P&L interest expense | 58.9 | 56.9 | 3.5% |
| Net debt / EBITDA | 0.4 | 0.8 | -50.9% |
| Sales (in HRKm) | 2021. | 2020. | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 4,666.5 | 4,526.5 | 3.1% |
| Sales revenues of Podravka Group | 4,631.5 | 4,503.2 | 2.8% |
| Sales revenues of Food | 3,601.3 | 3,527.0 | 2.1% |
| Sales revenues of Pharma | 1,030.3 | 976.2 | 5.5% |
| Podravka Group's profitability (in HRKm) | 2021. | 2020. | % change |
| Group's gross profit | 1,678.1 | 1,659.4 | 1.1% |
| Group's gross profit margin | 36.2% | 36.8% | -62 bb |
| Group's EBITDA | 592.0 | 546.7 | 8.3% |
| Group's EBITDA margin | 12.8% | 12.1% | +64 bb |
| Group's EBIT | 365.3 | 332.3 | 9.9% |
| Group's EBIT margin | 7.9% | 7.4% | +51 bb |
| Group's net profit after MI | 309.2 | 248.9 | 24.2% |
| Group's net profit margin after MI | 6.7% | 5.5% | +115 bb |
| Podravka Group's balance sheet (in HRKm) | 31.12.2021. | 31.12.2021. | % change |
| Total assets | 4,909.0 | 4,940.6 | -0.6% |
| Shareholders' equity | 1,090.3 | 951.2 | 14.6% |
| Minority interests | 822.2 | 714.8 | 15.0% |
| Cash and cash equivalents | 33.3 | 51.9 | -35.8% |
| Financial debt | 493.8 | 785.2 | -37.1% |
| Net debt | 460.5 | 733.3 | -37.2% |
| Podravka Group's cash flow (in HRKm) | 2021. | 2020. | % change |
| Net cash flow from operating activities | 517.1 | 384.5 | 34.5% |
| Capital expenditures | (170.3) | (192.4) | 37.8% |
| Depreciation and amortization | 218.2 | 218.2 | -0.0% |
| Free cash flow | 687.3 | 576.9 | 19.1% |
| Podravka Group's ratios and indicators | 31.12.2021 | 31.12.2020 | % change |
| Employee number at the end of period (in units) | 6,557 | 6,650 | -1.4% |
| P&L interest expense (in HRKm) | 6.8 | 11.5 | -20.9% |
| Sales revenues / Number of employees (in HRK000) | 706.3 | 677.2 | 4.3% |
| Net profit after MI / Sales revenues (in HRK000) | 47.2 | 37.4 | 26.0% |
| Return on average assets | 6.3% | 5.1% | +123 bb |
| Return on average capital | 8.8% | 7.6% | +121 bb |
| Return on average invested capital | 7.2% | 6.6% | +56 bb |
| Total shareholders' equity / Total assets | 75.3% | 69.4% | +589 bb |
| EBIT / P&L interest expense | 56.9 | 28.3 | 101.1% |
| Net debt / EBITDA | 0.8 | 1.4 | -43.9% |
| Sales (in HRKm) | 1-9 2021 | 1-9 2020 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 3,410.4 | 3,339.5 | 2.1% |
| Sales revenues of Podravka Group | 3,383.5 | 3,328.6 | 1.6% |
| Sales revenues of Food | 2,634.0 | 2,619.7 | 0.5% |
| Sales revenues of Pharma | 749.5 | 708.9 | 5.7% |
| Podravka Group's profitability (in HRKm) | 1-9 2021 | 1-9 2020 | % change |
| Group's gross profit | 1,248.9 | 1,232.5 | 1.3% |
| Group's gross profit margin | 36.9% | 37.0% | -12 bb |
| Group's EBITDA | 491.7 | 435.5 | 12.9% |
| Group's EBITDA margin | 14.5% | 13.1% | +145 bb |
| Group's EBIT | 328.4 | 272.7 | 20.4% |
| Group's EBIT margin | 9.7% | 8.2% | +151 bb |
| Group's net profit after MI | 259.3 | 210.1 | 23.4% |
| Group's net profit margin after MI | 7.7% | 6.3% | +135 bb |
| Podravka Group's balance sheet (in HRKm) | 30.9.2021 | 31.12.2020 | % change |
| Total assets | 5,113.7 | 4,940.6 | 3.5% |
| Shareholders' equity | 3,577.3 | 3,372.1 | 6.1% |
| Minority interests | 61.1 | 54.9 | 11.3% |
| Cash and cash equivalents | 163.5 | 51.9 | 215.3% |
| Financial debt | 613.5 | 785.2 | -21.9% |
| Net debt | 450.0 | 733.3 | -38.6% |
| Podravka Group's cash flow (in HRKm) | 1-9 2021 | 1-9 2020 | % change |
| Net cash flow from operating activities | 453.4 | 290.5 | 56.1% |
| Capital expenditures | (100.3) | (139.8) | 37.8% |
| Depreciation and amortization | 163.3 | 162.8 | 0.3% |
| Free cash flow | 553.8 | 430.2 | 28.7% |
| Podravka Group's ratios and indicators | 30.9.2021 | 31.12.2020 | % change |
| Employee number at the end of period (in units) | 6,746 | 6,650 | 1.4% |
| P&L interest expense (in HRKm) | 7.9 | 11.5 | -20.9% |
| Sales revenues / Number of employees (in HRK000) | 675.7 | 677.2 | -0.2% |
| Net profit after MI / Sales revenues (in HRK000) | 44.2 | 37.4 | 18.0% |
| Return on average assets | 6.0% | 5.1% | +89 bb |
| Return on average capital | 8.6% | 7.6% | +99 bb |
| Return on average invested capital | 7.7% | 6.6% | +107 bb |
| Total shareholders' equity / Total assets | 71.2% | 69.4% | +179 bb |
| EBIT / P&L interest expense | 48.2 | 28.3 | 70.5% |
| Net debt / EBITDA | 0.7 | 1.4 | -44.5% |
| Sales (in HRKm) | 1-6 2021 | 1-6 2020 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 2,238.2 | 2,252.3 | -0.6% |
| Sales revenues of Podravka Group | 2,220.5 | 2,245.3 | -1.1% |
| Sales revenues of Food | 1,716.6 | 1,755.0 | -2.2% |
| Sales revenues of Pharma | 503.9 | 490.3 | 2.8% |
| Podravka Group's profitability (in HRKm) | 1-6 2021 | 1-6 2020 | % change |
| Group's gross profit | 843.2 | 835.9 | 0.9% |
| Group's gross profit margin | 38.0% | 37.2% | +75 bb |
| Group's EBITDA | 356.6 | 320.1 | 11.4% |
| Group's EBITDA margin | 16.1% | 14.3% | +180 bb |
| Group's EBIT | 248.7 | 211.7 | 17.5% |
| Group's EBIT margin | 11.2% | 9.4% | +177 bb |
| Group's net profit after MI | 197.6 | 161.6 | 22.3% |
| Group's net profit margin after MI | 8.9% | 7.2% | +170 bb |
| Podravka Group's balance sheet (in HRKm) | 30.6.2021 | 31.12.2020 | % change |
| Total assets | 5,105.7 | 4,940.6 | 3.3% |
| Shareholders' equity | 3,513.0 | 3,372.1 | 4.2% |
| Minority interests | 59.0 | 54.9 | 7.4% |
| Cash and cash equivalents | 220.2 | 51.9 | 324.6% |
| Financial debt | 646.5 | 785.2 | -17.7% |
| Net debt | 426.3 | 733.3 | -41.9% |
| Podravka Group's cash flow (in HRKm) | 1-6 2021 | 1-6 2020 | % change |
| Net cash flow from operating activities | 359.7 | 280.0 | 28.5% |
| Capital expenditures | (56.5) | (91.3) | 37.8% |
| Depreciation and amortization | 107.8 | 108.4 | -0.5% |
| Free cash flow | 416.3 | 371.3 | 12.1% |
| Podravka Group's ratios and indicators | 30.6.2021 | 31.12.2020 | % change |
| Employee number at the end of period (in units) | 6,737 | 6,650 | 1.3% |
| P&L interest expense (in HRKm) | 9.2 | 11.5 | -20.9% |
| Sales revenues / Number of employees (in HRK000) | 664.7 | 677.2 | -1.8% |
| Net profit after MI / Sales revenues (in HRK000) | 42.3 | 37.4 | 13.0% |
| Return on average assets | 5.8% | 5.1% | +65 bb |
| Return on average capital | 8.3% | 7.6% | +72 bb |
| Return on average invested capital | 7.4% | 6.6% | +78 bb |
| Total shareholders' equity / Total assets | 70.0% | 69.4% | +60 bb |
| EBIT / P&L interest expense | 39.5 | 28.3 | 39.8% |
| Net debt / EBITDA | 0.7 | 1.4 | -45.8% |
| Sales (in HRKm) | 1-3 2021 | 1-3 2020 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 1,089.8 | 1,231.9 | -11.5% |
| Sales revenues of Podravka Group | 1,079.7 | 1,228.7 | -12.1% |
| Sales revenues of Food | 845.3 | 970.9 | -12.9% |
| Sales revenues of Pharma | 234.3 | 257.9 | -9.1% |
| Podravka Group's profitability (in HRKm) | 1-3 2021 | 1-3 2020 | % change |
| Group's gross profit | 411.8 | 457.2 | -9.9% |
| Group's gross profit margin | 38.1% | 37.2% | +94 bb |
| Group's EBITDA | 184.5 | 177.2 | 4.2% |
| Group's EBITDA margin | 17.1% | 14.4% | +267 bb |
| Group's EBIT | 131.1 | 123.0 | 6.6% |
| Group's EBIT margin | 12.1% | 10.0% | +214 bb |
| Group's net profit after MI | 105.2 | 91.0 | 15.6% |
| Group's net profit margin after MI | 9.7% | 7.4% | +234 bb |
| Podravka Group's balance sheet (in HRKm) | 31.03.2021 | 31.12.2020 | % change |
| Total assets | 5,126.9 | 4,940.6 | 3.8% |
| Shareholders' equity | 3,486.3 | 3,372.1 | 3.4% |
| Minority interests | 57.4 | 54.9 | 4.6% |
| Cash and cash equivalents | 178.1 | 51.9 | 243.4% |
| Financial debt | 785.2 | 744.7 | -5.2% |
| Net debt | 733.3 | 566.6 | -22.7% |
| Podravka Group's cash flow (in HRKm) | 1-3 2021 | 1-3 2020 | % change |
| Net cash flow from operating activities | 190.6 | 134.5 | 41.7% |
| Capital expenditures | 18.8 | 47.2 | -60.2% |
| Depreciation and amortization | 53.4 | 54.2 | -1.4% |
| Free cash flow | 171.8 | 87.3 | 96.8% |
| Podravka Group's ratios and indicators | 31.03.2021 | 31.12.2020 | % change |
| Employee number at the end of period (in units) | 6,668 | 6,650 | 0.3% |
| P&L interest expense (in HRKm) | 10.4 | 11.5 | -9.7% |
| Sales revenues / Number of employees (in HRK000) | 653.0 | 677.2 | -3.6% |
| Net profit after MI / Sales revenues (in HRK000) | 39.5 | 37.4 | 5.4% |
| Return on average assets | 5.3% | 5.1% | +18 bb |
| Return on average capital | 7.7% | 7.6% | +9 bb |
| Return on average invested capital | 6.7% | 6.5% | +17 bb |
| Total shareholders' equity / Total assets | 69.1% | 69.4% | -24 bb |
| EBIT / P&L interest expense | 32.4 | 28.3 | 14.5% |
| Net debt / EBITDA | 1.0 | 1.4 | -24.2% |
| Sales (in HRKm) | 2020 | 2019 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 4,526.5 | 4,460.2 | 1.5% |
| Sales revenues of Podravka Group | 4,503.2 | 4,409.4 | 2.1% |
| Sales revenues of Food | 3,527.0 | 3,454.0 | 2.1% |
| Sales revenues of Pharma | 976.2 | 955.4 | 2.2% |
| Podravka Group's profitability (in HRKm) | 2020 | 2019 | % change |
| Group's gross profit | 1,659.4 | 1,631.5 | 1.7% |
| Group's gross profit margin | 36.8% | 37.0% | -15 bb |
| Group's EBITDA | 546.7 | 509.0 | 7.4% |
| Group's EBITDA margin | 12.1% | 11.5% | +60 bb |
| Group's EBIT | 332.3 | 283.5 | 17.2% |
| Group's EBIT margin | 7.4% | 6.4% | + 95 bb |
| Group's net profit after MI | 248.9 | 221.6 | 12.3% |
| Group's net profit margin after MI | 5.5% | 5.0% | +50 bb |
| Podravka Group's balance sheet (in HRKm) | 31.12.2020 | 31.12.2019 | % change |
| Total assets | 4,940.6 | 4,883.8 | 1.2% |
| Shareholders' equity | 3,372.1 | 3,173.1 | 6.3% |
| Minority interests | 54.9 | 46.3 | 18.5% |
| Cash and cash equivalents | 51.9 | 55.6 | -6.6% |
| Financial debt | 785.2 | 878.0 | -10.6% |
| Net debt | 733.3 | 822.4 | -10.8% |
| Podravka Group's cash flow (in HRKm) | 2020 | 2019 | % change |
| Net cash flow from operating activities | 384.5 | 272.9 | 40.9% |
| Capital expenditures | 192.4 | 153.9 | 25.0% |
| Depreciation and amortization | 218.2 | 216.0 | 1.0% |
| Free cash flow | 192.1 | 119.0 | 61.4% |
| Podravka Group's ratios and indicators | 31.12.2020 | 31.12.2019 | % change |
| Employee number at the end of period (in units) | 6,650 | 6,652 | 2.0% |
| P&L interest expense (in HRKm) | 11.5 | 14.9 | -20.9% |
| Sales revenues / Number of employees (in HRK000) | 677.2 | 662.9 | 2.2% |
| Net profit after MI / Sales revenues (in HRK000) | 37.4 | 33.3 | 12.4% |
| Return on average assets | 5.1% | 4.7% | +41 bb |
| Return on average capital | 7.6% | 7.3% | +26 bb |
| Return on average invested capital | 6.5% | 6.3% | +23 bb |
| Total shareholders' equity / Total assets | 69.4% | 65.9% | +344 bb |
| EBIT / P&L interest expense | 28.3 | 20.1 | 40.5% |
| Net debt / EBITDA | 1.4 | 1.6 | -15.3% |
| Sales (in HRKm) | 1-9 2020 | 1-9 2019 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 3,339.5 | 3,261.3 | 2.4% |
| Sales revenues of Podravka Group | 3,328.6 | 3,238.5 | 2.8% |
| Sales revenues of Food | 2,619.7 | 2,550.3 | 2.7% |
| Sales revenues of Pharma | 708.9 | 688.2 | 3.0% |
| Podravka Group's profitability (in HRKm) | 1-9 2020 | 1-9 2019 | % change |
| Group's gross profit | 1,232.5 | 1,206.1 | 2.2% |
| Group's gross profit margin | 37.0% | 37.2% | -21 bb |
| Group's EBITDA | 435.5 | 413.2 | 5.4% |
| Group's EBITDA margin | 13.1% | 12.8% | +33 bb |
| Group's EBIT | 272.7 | 252.2 | 8.1% |
| Group's EBIT margin | 8.2% | 7.8% | +41 bb |
| Group's net profit after MI | 210.1 | 194.3 | 8.1% |
| Group's net profit margin after MI | 6.3% | 6.0% | +31 bb |
| Podravka Group's balance sheet (in HRKm) | 30.9.2020 | 31.12.2019 | % change |
| Total assets | 5,102.8 | 4,883.8 | 4.5% |
| Shareholders' equity | 3,329.6 | 3,173.1 | 4.9% |
| Minority interests | 50.7 | 46.3 | 9.4% |
| Cash and cash equivalents | 131.2 | 55.6 | 136.0% |
| Financial debt | 888.7 | 878.0 | 1.2% |
| Net debt | 757.5 | 822.4 | -7.9% |
| Podravka Group's cash flow (in HRKm) | 1-9 2020 | 1-9 2019 | % change |
| Net cash flow from operating activities | 290.5 | 175.7 | 65.3% |
| Capital expenditures | 139.8 | 101.4 | -37.8% |
| Depreciation and amortization | 162.8 | 161.1 | 1.1% |
| Free cash flow | 150.7 | 74.3 | 102.9% |
| Podravka Group's ratios and indicators | 30.9.2020 | 31.12.2019 | % change |
| Employee number at the end of period (in units) | 6,807 | 6,652 | 2.0% |
| P&L interest expense (in HRKm) | 11.8 | 14.9 | -20.9% |
| Sales revenues / Number of employees (in HRK000) | 661.0 | 662.9 | -0.3% |
| Net profit after MI / Sales revenues (in HRK000) | 34.9 | 33.3 | 4.7% |
| Return on average assets | 4.9% | 4.7% | +20 bb |
| Return on average capital | 7.4% | 7.3% | +11 bb |
| Return on average invested capital | 6.5% | 6.3% | +29 bb |
| Total shareholders' equity / Total assets | 66.2% | 65.9% | +32 bb |
| EBIT / P&L interest expense | 27.0 | 20.1 | 33.9% |
| Net debt / EBITDA | 1.4 | 1.6 | -11.2% |
| Sales (in HRKm) | 1-6 2020 | 1-6 2019 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 2,235.3 | 2,156.2 | 3.7% |
| Sales revenues of Podravka Group | 2,245.3 | 2,139.5 | 4.9% |
| Sales revenues of Food | 1,755.0 | 1,684.3 | 4.2% |
| Sales revenues of Pharma | 490.3 | 455.2 | 7.7% |
| Podravka Group's profitability (in HRKm) | 1-6 2020 | 1-6 2019 | % change |
| Group's gross profit | 835.9 | 803.8 | 4.0% |
| Group's gross profit margin | 37.2% | 37.6% | -34 bb |
| Group's EBITDA | 320.1 | 288.6 | 10.9% |
| Group's EBITDA margin | 14.3% | 13.5% | +77 bb |
| Group's EBIT | 211.7 | 182.9 | 15.8% |
| Group's EBIT margin | 9.4% | 8.5% | +88 bb |
| Group's net profit after MI | 161.6 | 140.0 | 15.4% |
| Group's net profit margin after MI | 7.2% | 6.5% | +65 bb |
| Podravka Group's balance sheet (in HRKm) | 30.6.2020 | 31.12.2019 | % change |
| Total assets | 5,100.9 | 4,883.8 | 4.4% |
| Shareholders' equity | 3,279.2 | 3,173.1 | 3.3% |
| Minority interests | 49.3 | 46.3 | 6.4% |
| Cash and cash equivalents | 249.2 | 55.6 | 348.3% |
| Financial debt | 966.0 | 878.0 | 10.0% |
| Net debt | 716.8 | 822.4 | -12.8% |
| Podravka Group's cash flow (in HRKm) | 1-6 2020 | 1-6 2019 | % change |
| Net cash flow from operating activities | 280.0 | 152.8 | 83.3% |
| Capital expenditures | 91.3 | 65.6 | 39.3% |
| Depreciation and amortization | 108.4 | 105.8 | 2.5% |
| Free cash flow | 188.7 | 87.2 | 116.4% |
| Podravka Group's ratios and indicators | 30.6.2020 | 31.12.2019 | % change |
| Employee number at the end of period (in units) | 6,785 | 6,652 | 2.0% |
| P&L interest expense (in HRKm) | 12.5 | 14.9 | -15.8% |
| Sales revenues / Number of employees (in HRK000) | 665.5 | 662.9 | 0.4% |
| Net profit after MI / Sales revenues (in HRK000) | 35.8 | 33.3 | 7.6% |
| Return on average assets | 5.0% | 4.7% | +26 bb |
| Return on average capital | 7.6% | 7.3% | +27 bb |
| Return on average invested capital | 6.5% | 6.3% | +29 bb |
| Total shareholders' equity / Total assets | 65.3% | 65.9% | -67 bb |
| EBIT / P&L interest expense | 25.8 | 20.1 | 28.1% |
| Net debt / EBITDA | 1.3 | 1.6 | -17.0% |
| Sales (in HRKm) | 1-3 2020 | 1-3 2019 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 1,198.0 | 1,030.6 | 16.2% |
| Sales revenues of Podravka Group | 1,228.7 | 1,017.4 | 20.8% |
| Sales revenues of Food | 970.9 | 815.5 | 19.1% |
| Sales revenues of Pharma | 257.9 | 201.9 | 27.7% |
| Podravka Group's profitability (in HRKm) | 1-3 2020 | 1-3 2019 | % change |
| Group's gross profit | 457.2 | 384.0 | 19.1% |
| Group's gross profit margin | 37.2% | 37.7% | -54 bb |
| Group's EBITDA | 177.2 | 156.5 | 13.2% |
| Group's EBITDA margin | 14.4% | 15.4% | -96 bb |
| Group's EBIT | 123.0 | 104.4 | 17.8% |
| Group's EBIT margin | 10.0% | 10.3% | -25 bb |
| Group's net profit after MI | 91.0 | 80.1 | 13.5% |
| Group's net profit margin after MI | 7.4% | 7.9% | -47 bb |
| Podravka Group's balance sheet (in HRKm) | 31.3.2020 | 31.12.2019 | % change |
| Total assets | 5,264.0 | 4,883.8 | 7.8% |
| Shareholders' equity | 3,275.7 | 3,173.1 | 3.2% |
| Minority interests | 47.6 | 46.3 | 2.8% |
| Cash and cash equivalents | 264.9 | 55.6 | 376.5% |
| Financial debt | 1,021.1 | 878.0 | 16.3% |
| Net debt | 756.2 | 822.4 | -8.0% |
| Podravka Group's cash flow (in HRKm) | 1-3 2020 | 1-3 2019 | % change |
| Net cash flow from operating activities | 134.5 | 50.3 | 167.6% |
| Capital expenditures | 47.2 | 24.1 | 95.7% |
| Depreciation and amortization | 54.2 | 52.1 | 4.1% |
| Free cash flow | 87.4 | 26.2 | 234.0% |
| Podravka Group's ratios and indicators | 31.3.2020 | 31.12.2019 | % change |
| Employee number at the end of period (in units) | 6,756 | 6,652 | 1.6% |
| P&L interest expense (in HRKm) | 13.7 | 14.9 | -8.0% |
| Sales revenues / Number of employees (in HRK000) | 683.9 | 662.9 | 3.2% |
| Net profit after MI / Sales revenues (in HRK000) | 34.4 | 33.3 | 3.3% |
| Return on average assets | 4.7% | 4.7% | +1 bb |
| Return on average capital | 7.3% | 7.3% | +1 bb |
| Return on average invested capital | 5.6% | 5.9% | -33 bb |
| Total shareholders' equity / Total assets | 63.1% | 65.9% | -279 bb |
| EBIT / P&L interest expense | 23.1 | 20.1 | 14.6% |
| Net debt / EBITDA | 1.4 | 1.6 | -11.2% |
| Sales (in HRKm) | 2019 | 2018 | % change |
|---|---|---|---|
| Total revenues of Podravka Group | 4,460.2 | 4,240.5 | 5.2% |
| Sales revenues of Podravka Group | 4,409.4 | 4,232.1 | 4.2% |
| Sales revenues of Food | 3,454.0 | 3,335.3 | 3.6% |
| Sales revenues of Pharma | 955.4 | 896.9 | 6.5% |
| Podravka Group's profitability (in HRKm) | 2019 | 2018 | % change |
| Group's gross profit | 1,631.5 | 1,558.4 | 4.7% |
| Group's gross profit margin | 37.0% | 36.8% | +18 bb |
| Group's EBITDA | 509.0 | 463.7 | 9.8% |
| Group's EBITDA margin | 11.5% | 11.0% | +59 bb |
| Group's EBIT | 283.5 | 258.4 | 9.7% |
| Group's EBIT margin | 6.4% | 6.1% | +32 bb |
| Group's net profit after MI | 221.6 | 205.7 | 7.7% |
| Group's net profit margin after MI | 5.0% | 4.9% | +16 bb |
| Podravka Group's balance sheet (in HRKm) | 2019 | 2018 | % change |
| Total assets | 4,883.8 |